Toxoplasmosis in Cats: Pathogenesis, Zoonotic Transmission, and Management

1. Introduction

Toxoplasmosis is a globally distributed zoonotic disease caused by the obligate intracellular apicomplexan parasite Toxoplasma gondii [1, 2, 27]. The parasite infects virtually all warm-blooded animals, but members of the family Felidae (domestic and wild cats) serve as the definitive hosts in which the sexual phase of the life cycle occurs [1, 3]. This singular role makes cats the most important host in the epidemiology of toxoplasmosis, as they are the only species capable of excreting environmentally resistant oocysts into the environment [1, 3, 20]. It is estimated that one third of the global human population has been infected by T. gondii [3, 27]. Infection in immunocompetent individuals is typically subclinical, but the disease can cause severe morbidity in immunocompromised hosts and developing fetuses, leading to substantial public health concern [2, 3]. This article provides a comprehensive review of the etiology, pathogenesis, clinical signs, diagnostic approaches, treatment, and control of toxoplasmosis in cats, with particular emphasis on zoonotic transmission risks.

2. Etiology and Life Cycle

Toxoplasma gondii is an obligate intracellular coccidian parasite belonging to the phylum Apicomplexa [2, 21]. The life cycle involves both definitive hosts (felids) and intermediate hosts (warm-blooded animals including humans, rodents, birds, and livestock) [1, 2]. Cats become infected by ingesting tissue cysts containing bradyzoites in the skeletal muscle or viscera of infected intermediate hosts, or by ingesting sporulated oocysts from contaminated food, water, or soil [1, 3, 4].

Following ingestion, the cyst wall is digested by gastric and small intestinal proteases, releasing bradyzoites that penetrate the enterocytes of the small intestine [4]. Within the intestinal epithelium, bradyzoites undergo multiple rounds of asexual replication (schizogony) producing merozoites, followed by the sexual cycle (gametogony) in which macrogametes and microgametes fuse to form a zygote [1, 4]. The zygote develops into an unsporulated oocyst that is shed in the feces [1, 4]. The prepatent period (time from infection to oocyst shedding) is typically 3 to 10 days after ingestion of tissue cysts but may be extended to 18 days or longer after oocyst ingestion [4, 23]. Cats shed oocysts for 1 to 3 weeks; during this period, a single cat can excrete millions of oocysts, contaminating the environment and facilitating widespread transmission [1, 3].

Outside the host, oocysts sporulate in the environment under appropriate conditions of temperature and humidity, becoming infective [1, 3]. Sporulated oocysts are highly resistant to environmental degradation and can remain viable for months to years in soil, water, and on surfaces [1, 20]. In intermediate hosts, including humans, ingested sporozoites (released from oocysts) or bradyzoites (released from tissue cysts) transform into rapidly dividing tachyzoites that disseminate systemically via the bloodstream and lymphatics [2, 27]. Tachyzoites invade virtually all nucleated cells, replicating intracellularly until host cell lysis, which leads to focal necrosis and inflammation [5, 15]. Under immune pressure, tachyzoites convert to bradyzoites and form tissue cysts, predominantly in the brain, skeletal muscle, and myocardium, establishing a chronic latent infection that persists for the life of the host [15, 27].

3. Epidemiology

Seroprevalence of T. gondii in domestic cat populations varies widely across geographic regions and study populations. In a study from the United States, approximately 30% of cats demonstrated serological evidence of exposure [32]. In Pakistan, seroprevalence in pet and stray cats ranged from 25.4% to 74.6% depending on the population and diagnostic method used [21]. A study in Greece reported a seroprevalence of 20.8% (95/457 cats) using an indirect immunofluorescence antibody test (IFAT) [33]. In Egypt, an immunochromatographic assay revealed overall seroprevalence of 38.67% (82/212 cats), with 29.71% positive for anti-T. gondii IgG and 8.96% positive for IgM [25]. A study in Bangladesh found a prevalence of 5.5% (14/254) in fecal samples from cats [3]. Rapid diagnostic test kits applied to 50 cats in Turkey yielded a prevalence of 6% [6]. In Thailand, the overall prevalence was 6.5% (17/260), with semi-domesticated cats showing significantly higher prevalence (11.5%) than client-owned pet cats (1.5%) [19]. A study in northeastern Brazil reported a frequency of anti-T. gondii antibodies of 41.5% (117/282) in cats [7].

Risk factors for seropositivity are multifactorial. Age is a consistently identified risk factor; older cats have higher seroprevalence than younger cats, reflecting cumulative lifetime exposure [3, 14, 21, 33]. Stray and outdoor-roaming cats demonstrate significantly higher infection rates than indoor-only pet cats due to increased opportunities for predation and environmental exposure [3, 19, 21]. A study from Pakistan found that stray cats had an infection rate of 74.6% versus 25.4% in pet cats [21]. In Thailand, odds of infection in semi-domesticated cats were 8.34 times higher than in pet cats [19]. Lack of regular vaccination against calicivirus, herpesvirus-1, panleukopenia, and rabies was also identified as a risk factor, potentially reflecting lower overall health care and owner attention [33]. Other significant risk factors include a history of cat-fight trauma, rural residence, and poor sanitation [30, 33]. Sex does not consistently appear as a risk factor, though some studies have reported higher seroprevalence in males [5, 21].

4. Pathogenesis and Clinical Signs

4.1 Pathogenesis

The pathogenesis of toxoplasmosis in cats depends on the stage of the parasite acquired, the route of infection, the immune status of the host, and the presence of concurrent infections or immunosuppressive conditions [5, 15, 34]. After ingestion of tissue cysts, bradyzoites invade the small intestinal epithelium and initiate the enteroepithelial cycle leading to oocyst production [4, 5]. Concurrently, bradyzoites may disseminate through the lymphatic and vascular systems, transforming into tachyzoites that replicate in various tissues (liver, lungs, brain, eyes, heart, skeletal muscle, pancreas) [5, 15].

In immunocompetent cats, clinical disease is often self-limiting, with rapid containment of tachyzoite replication by cell-mediated immunity (particularly IFN-gamma, CD4+ and CD8+ T cells) and conversion to the bradyzoite cyst stage [8, 14]. However, in immunocompromised cats (e.g., those coinfected with feline immunodeficiency virus or feline leukemia virus) or in very young kittens, uncontrolled tachyzoite proliferation leads to necrotizing lesions that can be fatal [7, 5, 32, 34]. Neonatal and young kittens are particularly susceptible to disseminated toxoplasmosis, which may be acquired transplacentally or postnatally [15, 32]. Genotype of the parasite also influences disease severity; some strains (e.g., ToxoDB genotype #4) have been associated with acute, fatal toxoplasmosis in kittens [32].

4.2 Clinical Signs

Clinical signs of toxoplasmosis are highly variable and often nonspecific. A large retrospective study of 100 histologically confirmed cases classified clinical presentations into generalized (36%), predominantly pulmonary (26%), abdominal (16%), neurologic (7%), neonatal (9%), and other forms including hepatic, pancreatic, cardiac, and cutaneous (collectively 6%) [5]. The most common clinical signs include fever (observed in 73% of febrile cats), dyspnea or polypnea, and abdominal discomfort [5].

Systemic and generalized toxoplasmosis is characterized by fever, lethargy, anorexia, weight loss, and evidence of multi-organ involvement [5, 24]. Hepatomegaly, splenomegaly, and lymphadenopathy may be present [5, 24]. Pulmonary involvement presents with tachypnea, dyspnea, and restrictive breathing patterns, often with pulmonary infiltrates visible on thoracic radiographs [5]. Abdominal form includes vomiting, diarrhea, icterus, and signs of pancreatitis or peritonitis [5, 24]. Ocular toxoplasmosis is a common sequela; in the retrospective study, 81.5% of examined eyes had evidence of intraocular inflammation [5]. Lesions include multifocal iridocyclochoroiditis, anterior uveitis, and retinal necrosis [5, 18]. Neurological toxoplasmosis may manifest as seizures, ataxia, paresis, circling, head tilt, and behavioral changes [9, 5]. Brain histology often reveals glial nodules, necrosis, and perivascular cuffing with demonstrable tachyzoites [5, 32]. Neonatal toxoplasmosis occurs in kittens infected in utero or shortly after birth, presenting with failure to thrive, hypothermia, abdominal distension, respiratory distress, and high mortality [5, 15, 32].

5. Diagnosis

5.1 Serological Methods

Serological detection of anti-T. gondii antibodies is the most widely used approach for antemortem diagnosis in cats. Multiple serological platforms are available, including the modified agglutination test (MAT), Sabin-Feldman dye test, indirect hemagglutination test, latex agglutination test, enzyme-linked immunosorbent assay (ELISA), and indirect fluorescence antibody test (IFAT) [6, 10, 25, 28].

The modified agglutination test using formalin-preserved tachyzoites is considered more sensitive than tests using acetone-preserved tachyzoites, and has been shown to detect antibodies for up to 29 months after infection [10]. IFAT is commonly used for detection of anti-T. gondii IgG; a cutoff of 1:100 is frequently applied [19, 33]. Commercial ELISA kits utilizing recombinant antigens such as SAG2, GRA6, GRA7, and GRA3 have been evaluated for serodiagnosis [28]. Among these, GRA7 demonstrated superior sensitivity for detecting T. gondii infection in cats, and GRA3 expressed in cell-free systems also showed promise as a priming antigen [28]. Immunochromatographic rapid diagnostic test kits (ICT) are popular in clinical settings due to their ease of use, cost-effectiveness, and rapid turnaround time, with sensitivity sufficient for population screening [6, 25]. A study in Turkey reported a 6% prevalence using rapid kits [6]. In Egypt, ICT detected IgM in 8.96% and IgG in 29.71% of samples from household cats [25].

Serological interpretation requires careful consideration. Detection of IgM may indicate recent infection or reactivation, while IgG persistence indicates chronic or past infection [21, 25]. Seronegativity does not rule out acute toxoplasmosis, especially if the cat is in the prepatent period or is immunocompromised [5, 10]. Conversely, seropositivity is common (20-40% in many populations) and does not equate with active clinical disease [1, 33].

5.2 Molecular Methods

Polymerase chain reaction (PCR) assays targeting the B1 gene or 529 bp repeat element provide sensitive detection of T. gondii DNA in blood, tissues, aqueous humor, cerebrospinal fluid, or bronchoalveolar lavage fluid [21, 34, 35]. Nested PCR and real-time PCR offer enhanced sensitivity compared to conventional PCR [34, 35]. In a comparative study from Iraq, real-time PCR showed higher detection rates (87.0%) in cat fecal samples than latex agglutination (7.6%) and nested PCR (60%) [35]. Molecular methods also allow genotyping through multilocus PCR-restriction fragment length polymorphism (Mn-PCR-RFLP) or multilocus sequence typing (MLST) to identify parasite strains [32, 34].

5.3 Microscopic and Histopathological Methods

Direct fecal examination using flotation or sedimentation techniques to detect oocysts is limited by intermittent shedding, low oocyst numbers, similar morphology to other coccidia (e.g., Hammondia hammondi, Besnoitia spp.), and the short shedding period (1-3 weeks) [1, 3, 30]. Immunohistochemical staining of tissue sections with anti-T. gondii antiserum provides definitive confirmation of tissue infection and is considered the gold standard for postmortem diagnosis [5]. Cytological examination of tracheal aspirates, pleural fluid, or biopsy specimens may reveal tachyzoites in acute cases [5].

5.4 Diagnostic Challenges and Interpretation

No single test provides definitive diagnosis of clinical toxoplasmosis. A diagnostic algorithm often combines serology, PCR, and clinical signs, with exclusion of other differential diagnoses such as feline infectious peritonitis, cryptococcosis, neoplasia, and other systemic infections [1, 5, 23]. Oocyst detection alone does not differentiate T. gondii from nonpathogenic coccidia of felids without confirmatory molecular testing or bioassay [1].

flowchart TD
    A[Clinical suspicion of toxoplasmosis in cat], > B{Serum anti-Toxoplasma IgG/IgM?}
    B, > |Positive IgG, negative IgM| C[Chronic/latent infection]
    B, > |Positive IgM or rising IgG| D{Active infection?}
    D, > E[Perform PCR on blood, CSF, aqueous humor, or BAL]
    E, > F[PCR positive]
    E, > G[PCR negative but strong clinical suspicion]
    F, > H[Confirm clinical toxoplasmosis; initiate therapy]
    G, > I[Consider histopathology / immunohistochemistry of biopsy]
    I, > J[Positive: treat; Negative: reassess differential diagnoses]
    B, > |Negative serology| K{Acute illness < 2 weeks?}
    K, > |Yes| L[Repeat serology in 2-4 weeks]
    K, > |No| M[Search for alternative diagnosis]
    L, > N[Seroconversion?]
    N, > |Yes| D
    N, > |No| M

6. Zoonotic Transmission and Public Health Implications

Cats are central to the zoonotic transmission of T. gondii because only felids can excrete oocysts, and these oocysts can contaminate soil, water, and food [1, 3, 19, 20]. Humans become infected by accidental ingestion of sporulated oocysts (via contaminated hands, food, or water), by consumption of undercooked meat containing tissue cysts, or by transplacental transmission from an infected pregnant woman to her fetus [2, 3, 27].

The phrase cat toxoplasmosis baby reflects the deep public health concern regarding toxoplasmosis in pregnant women. Primary maternal infection acquired during gestation can lead to congenital toxoplasmosis, resulting in spontaneous abortion, stillbirth, or severe neonatal disease including chorioretinitis, intracranial calcifications, hydrocephalus, and developmental delays [2, 35]. Risk of transmission increases with gestational age, but the severity of fetal disease is greatest when infection occurs early in pregnancy [2]. Although direct cat-to-human transmission via handling of the cat itself is negligible (cats typically do not excrete oocysts on their fur), the risk arises from contact with cat feces, particularly when cleaning litter boxes, or from contaminated gardening soil, sand boxes, and unwashed vegetables [1, 3, 29].

Community knowledge and awareness of toxoplasmosis remain low in many regions. In a study conducted in Unguja Island, Tanzania, only 18.0% of respondents were aware of toxoplasmosis, despite high rates of cat ownership and environmental contamination risk factors [29]. Among cat owners, 63.1% did not regularly deworm their cats, 70.8% did not clean cat kennels, and 53.1% did not wash hands after handling cats or cleaning kennels [29]. In Bangladesh, the presence of T. gondii oocysts in 5.5% of cat fecal samples and 3.08% of water samples underscores the contamination risk [3]. Grazing livestock can ingest oocysts from contaminated pasture, leading to tissue cyst formation in meat, which provides an additional foodborne transmission route to humans [3, 27].

Accordingly, domestic cats can serve as sentinel species for the presence of T. gondii in the environment, and their seroprevalence correlates with the risk of human exposure [20]. Strict hygiene measures, including daily removal of cat feces (before oocysts sporulate and become infective within 1-5 days), hand washing after contact with cat litter or soil, and avoiding feeding raw meat to cats, are critical components of preventing zoonotic transmission [1, 23]. Pregnant women and immunocompromised individuals should be advised to avoid cleaning cat litter boxes altogether or to use gloves and masks if unavoidable [1, 2, 29].

7. Treatment

Treatment of clinical toxoplasmosis in cats involves the administration of antiprotozoal agents, primarily clindamycin, in combination with supportive care [17, 23, 31].

Clindamycin is the first-line therapeutic agent. The recommended dosage is 10-12 mg/kg administered orally or intramuscularly every 12 hours for 2-4 weeks [17, 23]. In experimentally induced acute toxoplasmosis in cats, clindamycin was effective in reducing fever and improving clinical signs, but a paradoxical effect was noted wherein clindamycin-treated cats developed higher antibody titers and some showed delayed but ultimately resolved disease, underscoring the importance of host immunity [17]. In Pallas' cats (Otocolobus manul), a species highly susceptible to fatal toxoplasmosis, prophylactic use of clindamycin reduced first-year mortality rates by 67% (from 20.6% to 5.88%) [31].

The standard combination of pyrimethamine (0.5-1.0 mg/kg once daily) and sulfadiazine or trimethoprim-sulfonamide (15 mg/kg twice daily) is also used, particularly in refractory cases [23]. However, these drugs can cause bone marrow suppression (pyrimethamine) and keratoconjunctivitis sicca (sulfonamides) in cats, requiring close monitoring.

Other agents that have been investigated include ponazuril (toltrazuril sulfone), which at a dose of 20 mg/kg orally once daily for 3-5 days has shown efficacy in reducing oocyst shedding, and diclazuril [8, 23]. Supportive care is essential, including fluid therapy, nutritional support, oxygen therapy for dyspneic cats, and anti-inflammatory doses of corticosteroids (e.g., prednisolone 1-2 mg/kg/day) for cats with severe ocular or neurological inflammation to reduce inflammatory tissue damage [5, 23].

Vaccination against toxoplasmosis in cats remains experimental. A live attenuated strain (RHΔompdcΔuprt) constructed using the CRISPR-Cas9 system induced strong humoral and cell-mediated immune responses in mice and cats, resulting in 95.3% reduction in oocyst shedding after challenge [8]. However, no licensed commercial vaccine for feline toxoplasmosis is currently available [1, 8].

8. Control and Prevention

Control of toxoplasmosis in cats centers on reducing environmental contamination with oocysts and preventing infection of the definitive host [1, 23, 29].

Prevention strategies include:

• Feeding cats only commercial cooked or canned cat food, never raw or undercooked meat, viscera, or unpasteurized milk [1, 3, 23, 32].
• Preventing hunting and scavenging by keeping cats indoors, especially at night [19, 23].
• Daily removal of cat feces from litter boxes (before oocysts sporulate and become infective, which requires 1-5 days depending on temperature) [1, 23].
• Disposing of cat feces in sealed plastic bags and not into garden compost or open waste [23, 29].
• Thorough hand washing after handling cat litter or gardening [1, 29].
• Covering children's sandboxes when not in use to prevent cat defecation [1, 23].
• Washing fruits and vegetables thoroughly before consumption [3].
• Proper management of stray cat populations to reduce environmental contamination [6, 30, 33].

For pregnant women, the risk of acquiring toxoplasmosis from pet cats can be minimized by having another household member clean the litter box daily. If the pregnant woman must perform this task, wearing disposable gloves and a mask and washing hands immediately afterward is recommended [1, 2, 23].

9. Conclusions

Toxoplasmosis in cats is a significant parasitic disease with major implications for both feline health and human public health. Cats are essential to the life cycle of T. gondii because they are the only hosts that shed oocysts into the environment. Seroprevalence is high in many populations (20-40%), though clinical disease is relatively uncommon and is most often associated with young age, concurrent immunosuppression, or highly virulent parasite strains. Diagnosis relies on a combination of serology, PCR, cytology, and histopathology, with careful interpretation required to differentiate active infection from latent exposure. Treatment with clindamycin is effective in most cases. Control measures, including strict hygiene, indoor management, and avoidance of raw meat diets, are essential to reduce zoonotic transmission to humans, particularly pregnant women and immunocompromised individuals. Further research into effective vaccines for cats and improved public education on disease prevention are needed to reduce the global burden of this zoonotic parasite.

References

[1] J. Dubey, C. K. Cerqueira-Cézar, F. Murata et al. All about toxoplasmosis in cats: the last decade. Veterinary Parasitology, 2020. URL: https://www.semanticscholar.org/paper/f0acbbba7cd9f8c048d5d0764bbf9a13fc7c158b

[2] C. Wingertzahn, P. Sharma. Toxoplasmosis in Cats and Humans. Journal of Student-Scientists' Research, 2022. URL: https://www.semanticscholar.org/paper/834520fe7a4cfa2fadd9472ea612128cc9530feb

[3] R. Sah, M. Talukder, A. Rahman et al. Toxoplasmosis in Cats and Its Zoonotic Potential in and Around Bangladesh Agricultural University Campus. Nepalese Veterinary Journal, 2019. URL: https://www.semanticscholar.org/paper/66ae020a23bb626bc6c2d5f9aa9043e857de9c26

[4] J. Dubey, J. K. Frenkel. Cyst-induced toxoplasmosis in cats. The Journal of Protozoology, 1972. URL: https://www.semanticscholar.org/paper/12d02c2160648955e5516f3c6df5f8ca6fc8d0c9

[5] J. Dubey, J. Carpenter. Histologically confirmed clinical toxoplasmosis in cats: 100 cases (1952-1990). Journal of the American Veterinary Medical Association, 1993. URL: https://www.semanticscholar.org/paper/d52209abc2a6337a4c9d08f712a537010200385e

[6] Y. Parlatır, Y. Senel, E. Kara. Determination of the Prevalance of Toxoplasmosis in Cats with Immunochoromatographic Rapid Tests Kits in Kırıkkale University Veterinary Faculty Animal Hospital. Research and Practice in Veterinary and Animal Science, 2025. URL: https://www.semanticscholar.org/paper/247f3db5fd827af96d636da4d3164d751074874f

[7] A. Munhoz, S. B. Hage, R. Cruz et al. Toxoplasmosis in cats in northeastern Brazil: Frequency, associated factors and coinfection with Neospora caninum, feline immunodeficiency virus and feline leukemia virus. Veterinary Parasitology: Regional Studies and Reports, 2017. URL: https://www.semanticscholar.org/paper/7c8a2fdd2e9561c2569bc4e98397bbe347e630a2

[8] Y. Shen, B. Zheng, H. Sun et al. A live attenuated RHΔompdcΔuprt mutant of Toxoplasma gondii induces strong protective immunity against toxoplasmosis in mice and cats. Infectious Diseases of Poverty, 2023. URL: https://www.semanticscholar.org/paper/2c0eccd9ce92a1acbb4617baa6621f2d56e59c5e

[9] C. Cucoș, I. Ionașcu, J. Mocanu et al. Neurological and ocular form of toxoplasmosis in cats. 2015. URL: https://www.semanticscholar.org/paper/aa122640585a7963211031f376cc4dfc5aad4bb2

[10] J. Dubey, P. Thulliez. Serologic diagnosis of toxoplasmosis in cats fed Toxoplasma gondii tissue cysts. Journal of the American Veterinary Medical Association, 1989. URL: https://www.semanticscholar.org/paper/ee22536cb0d4e9d5bd35bdcff522943c207f2843

[11] N. Ahmad, H. Ahmed, S. Irum et al. Seroprevalence of IgG and IgM antibodies and associated risk factors for toxoplasmosis in cats and dogs from sub-tropical arid parts of Pakistan. Tropical Biomedicine, 2014. URL: https://www.semanticscholar.org/paper/da6e18e25d3ce94af78a72a188b4814bde5a4bf6

[12] Y. Al-Kappany, C. Rajendran, L. R. Ferreira et al. High Prevalence of Toxoplasmosis in Cats from Egypt: Isolation of Viable Toxoplasma gondii, Tissue Distribution, and Isolate Designation. Journal of Parasitology, 2010. URL: https://www.semanticscholar.org/paper/eb0cb3755cb9a332123f4cff955b60832811f357

[13] A. Shahzad, M. S. Khan, K